Software developer Voxar has agreed to license several PointDx patents related to virtual endoscopy. This is the second such deal in recent months. The last assigned licenses to Siemens regarding virtual endoscopy patents held by PointDx (SCAN 10/9/03).
Software developer Voxar has agreed to license several PointDx patents related to virtual endoscopy. This is the second such deal in recent months. The last assigned licenses to Siemens regarding virtual endoscopy patents held by PointDx (SCAN 10/9/03).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.